vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and IMAX CORP (IMAX). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $77.6M, roughly 1.6× Bioceres Crop Solutions Corp.). IMAX CORP runs the higher net margin — 0.5% vs -9.6%, a 10.1% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs -16.8%). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
BIOX vs IMAX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $125.2M |
| Net Profit | $-7.4M | $637.0K |
| Gross Margin | 46.8% | 57.6% |
| Operating Margin | 9.3% | 19.3% |
| Net Margin | -9.6% | 0.5% |
| Revenue YoY | -16.8% | 35.1% |
| Net Profit YoY | -20.2% | -88.0% |
| EPS (diluted) | $-0.12 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $125.2M | ||
| Q3 25 | $77.6M | $106.7M | ||
| Q2 25 | — | $91.7M | ||
| Q1 25 | $60.6M | $86.7M | ||
| Q4 24 | $98.8M | $92.7M | ||
| Q3 24 | $93.3M | $91.5M | ||
| Q2 24 | — | $89.0M | ||
| Q1 24 | $84.0M | $79.1M |
| Q4 25 | — | $637.0K | ||
| Q3 25 | $-7.4M | $20.7M | ||
| Q2 25 | — | $11.3M | ||
| Q1 25 | $-1.6M | $2.3M | ||
| Q4 24 | $605.2K | $5.3M | ||
| Q3 24 | $-6.2M | $13.9M | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | $9.8M | $3.3M |
| Q4 25 | — | 57.6% | ||
| Q3 25 | 46.8% | 63.1% | ||
| Q2 25 | — | 58.5% | ||
| Q1 25 | 39.4% | 61.4% | ||
| Q4 24 | 42.0% | 52.2% | ||
| Q3 24 | 40.2% | 55.8% | ||
| Q2 24 | — | 49.4% | ||
| Q1 24 | 50.8% | 59.3% |
| Q4 25 | — | 19.3% | ||
| Q3 25 | 9.3% | 27.2% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | 1.5% | 19.3% | ||
| Q4 24 | 14.5% | 10.3% | ||
| Q3 24 | 2.5% | 21.2% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | 15.7% | 15.3% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | -9.6% | 19.4% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | -2.6% | 2.7% | ||
| Q4 24 | 0.6% | 5.7% | ||
| Q3 24 | -6.6% | 15.2% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | 11.6% | 4.1% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | $-0.12 | $0.37 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | $-0.02 | $0.04 | ||
| Q4 24 | $0.00 | $0.09 | ||
| Q3 24 | $-0.10 | $0.26 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | $0.14 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $151.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $288.3M | $337.9M |
| Total Assets | $734.9M | $894.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $151.2M | ||
| Q3 25 | $15.5M | $143.1M | ||
| Q2 25 | — | $109.3M | ||
| Q1 25 | $38.5M | $97.1M | ||
| Q4 24 | $29.2M | $100.6M | ||
| Q3 24 | $32.3M | $104.5M | ||
| Q2 24 | — | $91.6M | ||
| Q1 24 | $16.4M | $81.0M |
| Q4 25 | — | $337.9M | ||
| Q3 25 | $288.3M | $349.5M | ||
| Q2 25 | — | $320.4M | ||
| Q1 25 | $345.0M | $299.5M | ||
| Q4 24 | $346.3M | $299.5M | ||
| Q3 24 | $346.0M | $289.4M | ||
| Q2 24 | — | $267.2M | ||
| Q1 24 | $348.5M | $258.8M |
| Q4 25 | — | $894.0M | ||
| Q3 25 | $734.9M | $889.6M | ||
| Q2 25 | — | $868.6M | ||
| Q1 25 | $798.2M | $848.3M | ||
| Q4 24 | $835.2M | $830.4M | ||
| Q3 24 | $827.3M | $847.6M | ||
| Q2 24 | — | $827.4M | ||
| Q1 24 | $836.1M | $824.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $29.4M |
| Free Cash FlowOCF − Capex | — | $28.0M |
| FCF MarginFCF / Revenue | — | 22.3% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | — | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.4M | ||
| Q3 25 | $14.4M | $67.5M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | $23.3M | $7.0M | ||
| Q4 24 | $-5.4M | $11.5M | ||
| Q3 24 | $5.2M | $35.3M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | $-17.4M | $-11.0M |
| Q4 25 | — | $28.0M | ||
| Q3 25 | — | $64.8M | ||
| Q2 25 | — | $20.9M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | — | $34.2M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $-12.1M |
| Q4 25 | — | 22.3% | ||
| Q3 25 | — | 60.7% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 37.6% | ||
| Q1 24 | — | -15.3% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | 46.11× | ||
| Q3 25 | — | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | -8.85× | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | -1.78× | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
